Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selecting for Cetuximab Responders in Advanced Head and Neck SCC

NCT02177838 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT02177838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02177838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selecting for Cetuximab Responders in Advanced Head and Neck SCC
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Not applicable
Overall status
Terminated
Start date
March 25, 2015
Completion date
August 22, 2019
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii squamous cell carcinoma of the hypopharynx, stage iii squamous cell carcinoma of the larynx, stage iii squamous cell carcinoma of the oropharynx, stage iii verrucous carcinoma of the larynx, stage iv squamous cell carcinoma of the hypopharynx, stage iva squamous cell carcinoma of the larynx, stage iva squamous cell carcinoma of the oropharynx, stage iva verrucous carcinoma of the larynx, stage ivb squamous cell carcinoma of the larynx, stage ivb squamous cell carcinoma of the oropharynx, stage ivb verrucous carcinoma of the larynx, tongue cancer